Frequently asked questions about low testosterone and TRT

Symptoms can raise suspicion, but they do not confirm the diagnosis. Guidelines require two things: compatible symptoms or signs and reliably low testosterone. If the first result is low, it is usually repeated before treatment decisions are made.

In practice, assessment normally starts with a morning total testosterone test and a repeat test if it is low. The result is then interpreted alongside symptoms, SHBG and, when appropriate, LH, FSH or other tests. The aim is to avoid treating a temporarily low result as a permanent disease.

Source: EAU 2026.

The symptoms that point most strongly towards low testosterone are sexual: a persistent fall in sexual desire and fewer spontaneous or morning erections. Fatigue, low mood, loss of strength and increased body fat can occur too, but they have many other causes.

Sexual symptoms generally carry more weight because they are relatively more specific. Loss of muscle mass, anaemia, lower bone density or changes in body hair can occur with more prolonged deficiency, but none of these findings is unique to hypogonadism. The overall pattern matters more than one symptom.

Source: EAU 2026.

Yes. A blood result can be low even when a person has no clear symptoms. That does not automatically mean they have clinical hypogonadism or need testosterone treatment.

This can happen during illness, with obesity or because of certain medicines. If the person feels well and the result is unexpected, it is usually more sensible to repeat the test and understand the context before assuming TRT is needed.

Source: EAU 2026.

No. Tiredness is common in men with low testosterone, but it is one of the least specific symptoms. It is also common with poor sleep, depression, anaemia, thyroid disease, diabetes, alcohol, medicines and many other conditions.

If tiredness is the main problem, sleep, anaemia, thyroid function, mental health, medicines and metabolic health should usually be considered as well. Testosterone can be part of the assessment, but it should rarely be the only explanation considered.

Source: EAU 2026.

Not usually on its own. Erectile dysfunction has many possible causes, including vascular disease, diabetes, medicines, nerve problems and psychological factors. Low testosterone is one possible contributor.

When testosterone is clearly low it may contribute, especially if reduced libido is also present. But an erection depends on blood vessels, nerves, medicines, cardiometabolic health and psychological factors, so hormone treatment does not replace a broader assessment.

Source: EAU 2026.

No. Scalp hair loss is not a reliable sign of low testosterone. Hair growth depends on genetics, androgen sensitivity, age and many other factors.

Male-pattern hair loss, for example, depends mainly on genetic susceptibility and the follicle's response to androgens. The amount of hair you have cannot tell you how much testosterone is circulating or whether you have hypogonadism.

Source: EAU 2026.

It can be associated with low testosterone, but low mood is very non-specific. Depression, anxiety, poor sleep, chronic illness, medicines and life circumstances can cause similar symptoms.

In some men with confirmed hypogonadism mood may improve partly when the deficiency is treated, but the response is not uniform. Depression or another mental health condition should still be assessed and treated in its own right rather than being attributed automatically to a hormone level.

Source: EAU 2026.

Testing is most useful when there are persistent symptoms or signs that could fit hypogonadism, rather than as a general screening test for every man.

It is particularly reasonable with persistent loss of libido, fewer spontaneous erections, infertility, unexplained osteoporosis, relevant testicular or pituitary history, or exposure to medicines that suppress the hormonal axis. A clinician can decide when the context justifies a broader work-up.

Source: EAU 2026.

For most men, total testosterone should be measured in the morning, usually between 07:00 and 10:00, and preferably fasting. Testosterone follows a daily rhythm and tends to be higher in the morning.

For night-shift workers or people with an unusual sleep schedule, timing may need to be adapted to the sleep-wake cycle and clinical judgement rather than applying a clock time mechanically.

Source: EAU 2026.

Usually, yes. A low result is normally repeated on another morning before diagnosing hypogonadism or starting TRT.

Repeating the test reduces the risk of making treatment decisions based on normal biological or laboratory variation. Ideally the second sample is taken under similar conditions when you are clinically stable. Two concordant results give a much stronger basis for the next decision.

Source: EAU 2026.

Yes. Acute illness can temporarily lower testosterone, so a result taken during a significant infection, hospital admission or early recovery may not represent your usual level.

This is why acute illness is usually a poor time to diagnose hypogonadism. Unless there is a specific clinical reason to act sooner, the test can often be repeated once health has stabilised.

Source: EAU 2026.

There is no single number that diagnoses every man. Laboratory ranges differ and the result must be interpreted alongside symptoms and the circumstances of the test.

The EAU uses about 12 nmol/L as a practical threshold in late-onset hypogonadism, but it is not a magic dividing line. Near the threshold, SHBG and calculated free testosterone can be especially helpful when the total testosterone does not fit the clinical picture.

Source: EAU 2026.

Twelve nmol/L of total testosterone is approximately 346 ng/dL. The site calculator uses the same mathematical conversion.

Converting the units helps compare laboratory reports, but it does not change the clinical interpretation. A value around 346 ng/dL is not automatically normal or abnormal without symptoms, repeat testing and context.

Source: EAU 2026.

Total testosterone includes testosterone that is free and testosterone bound to proteins, mainly SHBG and albumin. Free testosterone is the small fraction that is not protein-bound.

SHBG can change with age, obesity, liver disease, thyroid disorders and other factors. Free or calculated free testosterone is therefore most useful when SHBG is abnormal or when total testosterone does not fit the symptoms.

Source: EAU 2026.

SHBG stands for sex hormone-binding globulin. It is one of the main proteins that carries testosterone in the blood and it affects how total testosterone should be interpreted.

Low SHBG can make total testosterone look lower than the free fraction would suggest; high SHBG can do the opposite. Measuring it can stop an apparently simple total testosterone result from being misleading.

Source: EAU 2026.

LH and FSH are pituitary hormones that help show where the problem may be coming from. They are often checked after low testosterone has been confirmed.

Low testosterone with high LH/FSH suggests the testes are not responding adequately. Low testosterone with low or inappropriately normal LH/FSH can suggest a central or functional problem. That distinction can change the next tests and treatment.

Source: EAU 2026.

Prolactin is often useful when low testosterone appears to be secondary to a pituitary problem, when libido is markedly reduced or when the rest of the hormonal pattern suggests it.

Raised prolactin can interfere with gonadal function and may point to a pituitary or medication-related cause. If it is elevated, the degree of elevation, repeat testing, symptoms and medicines all matter before conclusions are drawn.

Source: EAU 2026.

Yes. Obesity is one of the commonest associations with lower testosterone. It can lower SHBG and can also suppress the hypothalamic-pituitary-testicular axis.

When the fall is functional, weight loss and treatment of associated conditions may improve the hormonal profile. But it is still important not to assume that every low testosterone result in a man with obesity is caused only by weight.

Source: EAU 2026.

Yes. Short or disrupted sleep and some sleep disorders can affect testosterone levels, and obstructive sleep apnoea is clinically relevant in men being assessed for hypogonadism.

Poor sleep can also cause some of the same symptoms often blamed on testosterone, including fatigue, poor concentration and reduced sexual function. Looking for sleep apnoea or another sleep disorder can be as important as measuring testosterone.

Source: EAU 2026.

Yes. Opioids are a classic example, and glucocorticoids, some cancer treatments and other medicines can also affect the hormonal axis.

Current or previous testosterone or anabolic-steroid use can suppress the body's own production as well. Do not stop prescribed medicines on your own; the useful step is to review with a clinician whether a medicine may be contributing.

Source: EAU 2026.

No. Testosterone can change with age, but age is only one part of the picture. Weight, illness, sleep, medicines and changes in SHBG are also important.

Two men of the same age can have very different levels and symptoms. Assessment should distinguish physiological ageing from disease, medication effects, obesity, sleep disorders and testicular or pituitary causes.

Source: EAU 2026.

In primary hypogonadism the main problem is in the testes. In secondary hypogonadism the hypothalamus or pituitary is not providing enough hormonal stimulation.

The distinction matters because it points towards different causes. A testicular problem may require investigation of testicular damage or disease; a central problem may lead to prolactin testing, assessment of other pituitary hormones or, in selected cases, pituitary imaging.

Source: EAU 2026.

Yes, in some situations. Testosterone may improve when a reversible factor such as obesity, poor sleep, systemic illness, a medicine or recovery after anabolic steroids improves.

The possibility of reversibility is one reason to investigate the cause before deciding that long-term testosterone replacement is the only option.

Source: EAU 2026.

TRT means testosterone replacement therapy. It is treatment intended to replace testosterone when a man has clinically confirmed hypogonadism.

The word replacement matters: the goal is to restore an inadequate level to a physiological range and improve relevant symptoms, not to push testosterone above normal or maximise a laboratory number.

Source: EAU 2026.

No. A low result is usually the start of an assessment, not an automatic indication for treatment. It should normally be confirmed and interpreted with symptoms and the underlying cause.

If a reversible cause is present, or if there are no compatible symptoms, TRT may not be the best first step. The diagnosis should come before the prescription.

Source: EAU 2026.

Authorised testosterone products in Spain include transdermal gels and injectable preparations. All require a medical prescription.

Gels allow relatively steady exposure and easier dose adjustment but require daily use and precautions against skin transfer. Injections have different durations and peak-trough profiles. Choice depends on preference, response, safety, availability and follow-up.

Source: AEMPS CIMA.

In men with confirmed hypogonadism, libido is one of the symptoms with the clearest evidence of improvement from testosterone replacement.

Improvement is more likely when reduced libido is genuinely part of hypogonadism. If libido stays low after testosterone has normalised, other causes such as medicines, relationships, sleep, depression or illness should be reconsidered.

Source: EAU 2026.

It can increase lean mass, but changes in energy and strength are less predictable than changes in some sexual symptoms.

If someone expects a rapid transformation in performance, expectations should be reset and sleep, nutrition, exercise and other medical causes considered as well. A higher dose is not automatically a better treatment.

Source: EAU 2026.

Not necessarily. In a man with hypogonadism it may improve sexual function, but erectile dysfunction often has vascular, metabolic, neurological, medication-related or psychological causes as well.

Some men still need treatment directed specifically at erections. An incomplete response does not automatically mean the testosterone dose should keep being increased.

Source: EAU 2026.

Not always. If the cause is permanent, treatment may be long term. If the cause is functional or changes over time, reassessment may be appropriate.

TRT may also be stopped because it is not helping, because of adverse effects, a change in fertility plans or a new medical condition. The reason for treatment should be reviewed over time.

Source: EAU 2026.

Monitoring usually includes symptoms, adverse effects, testosterone and a full blood count with haematocrit. Prostate assessment is added when appropriate for age and individual risk.

The timing of testosterone measurement depends on the product: a value measured at a peak or trough can mean very different things. Blood pressure, PSA where appropriate, urinary symptoms and other parameters may also be reviewed.

Source: EAU 2026.

Erythrocytosis means an excessive rise in red blood cells, reflected by a raised haematocrit. Testosterone can cause this, particularly with some preparations.

A high haematocrit requires review because it can increase blood viscosity. Management may involve reducing the dose, changing the interval or formulation, pausing treatment and looking for other contributors such as smoking, hypoxia or sleep apnoea.

Source: EAU 2026.

The TRAVERSE trial was reassuring for major cardiovascular events in a specific population of men with hypogonadism and raised cardiovascular risk: testosterone was not inferior to placebo for the primary cardiovascular outcome.

That does not make testosterone a cardiovascular prevention treatment or prove it is risk-free for every man. A recent cardiovascular event, previous thrombosis or other risk factors can change the decision and the monitoring plan.

Source: TRAVERSE, N Engl J Med · Endocrine Society 2026.

Current evidence does not support the simple statement that TRT automatically causes prostate cancer. However, prostate health still matters because treatment can affect PSA and suspected or known prostate cancer changes the treatment decision.

Before and during treatment, prostate assessment is individualised by age and risk. An unexpected rise in PSA needs explanation rather than being ignored or attributed automatically to TRT.

Source: EAU 2026.

That is not the medical purpose of replacement therapy. TRT is intended to treat confirmed deficiency, not to push a normal testosterone level higher.

Pursuing supraphysiological or unnecessarily high levels may increase risks such as erythrocytosis, infertility and androgen-related adverse effects without clear evidence of medical benefit.

Source: EAU 2026.

The process starts with a medical consultation rather than buying the medicine. A doctor should assess symptoms, confirm low testosterone, investigate the cause and review safety and fertility.

A reasonable pathway is consultation, confirmatory morning blood tests, additional investigations where needed, a safety and fertility review, a medical decision and prescription. There should then be a genuine follow-up plan; a prescription without monitoring is not the same as well-managed treatment.

Source: AEMPS CIMA · Royal Decree 1718/2010.

Assessment can begin in primary care or with a private doctor. Depending on the cause and complexity, urology, endocrinology or andrology may become involved.

You do not necessarily need to start in a hospital specialist clinic. The important point is that the doctor can assess the problem properly and knows when to refer, for example for infertility, suspected pituitary disease, complex testicular disease or safety concerns.

Source: EAU 2026.

Yes. Telemedicine can be appropriate for history-taking, reviewing blood tests, discussing treatment and follow-up when the service can identify the patient and obtain enough clinical information.

Some situations still require a physical examination or in-person testing. A serious online service should have a clear route for arranging that care when needed. Being online does not make the prescription automatic.

Source: EAU 2026 · Spanish General Medical Council.

For suspected hypogonadism, yes. Treatment should be based on demonstrated hormonal deficiency and compatible symptoms. A low morning testosterone usually needs confirming on another day.

Depending on the case, the doctor may also need LH, FSH, SHBG, prolactin, a full blood count and tests directed at the underlying cause. The work-up is not identical for everyone.

Source: EAU 2026 · AEMPS CIMA.

A single low result is not usually enough to confirm hypogonadism. Guidelines normally recommend repeating a low testosterone result before starting treatment.

An exception should not become the routine. If a decision is made from one measurement, there should be a clear clinical reason. For most people, repeating the test substantially reduces the risk of treating a temporary variation.

Source: EAU 2026.

Yes. Private electronic prescription systems can be used in Spain when they meet the applicable requirements.

An electronic prescription changes the format, not the medical responsibility. The prescriber still needs to make the clinical decision and arrange appropriate follow-up.

Source: Royal Decree 1718/2010.

A valid prescription is dispensed through an authorised pharmacy, subject to the product being available and the prescription meeting the applicable requirements.

Stock can vary by formulation and location. If a pharmacy does not have the medicine, it may be able to order it, but a change of product or dose should go back to the prescriber rather than being decided solely because of stock.

Source: AEMPS CIMA.

Warning signs include promising testosterone before reviewing blood tests, treating a normal result as a disease, selling 'optimisation' as the goal, failing to ask about fertility or not identifying the responsible doctor.

It is also a concern if the service cannot explain what happens when the blood tests do not confirm hypogonadism, how adverse effects are handled, or how follow-up works. A good service must be able to say no when treatment is not indicated.

Source: EAU 2026.

There should be a follow-up plan. The doctor checks whether symptoms improve, whether testosterone is in an appropriate range and whether adverse effects are developing.

Early follow-up checks tolerance and exposure; later frequency is adapted to stability and risk. If testosterone normalises but symptoms do not improve, the diagnosis should be reconsidered rather than simply increasing the dose.

Source: EAU 2026.

No. TRT is not a fertility treatment and in many men it does the opposite: external testosterone suppresses the hormonal signals the testes need to produce sperm.

Sperm counts can fall substantially and may reach azoospermia. Fertility should therefore be discussed before TRT is started, not only after a problem appears.

Source: EAU 2026.

If you want children now or in the near future, this should be discussed before starting testosterone. External testosterone can markedly suppress sperm production.

When near-term fatherhood is a priority, the cause of hypogonadism should be investigated and strategies that preserve testicular function considered. The plan can be very different from that for a man who is not seeking fertility.

Source: EAU 2026.

Recovery is common, but it is not immediate and it is not identical in every man. It can take months and depends on age, duration of exposure, previous testicular function and other factors.

Recovery may be gradual and sometimes needs specialist assessment. If having children by a particular date matters to you, it is not sensible to assume fertility will return on an exact timetable.

Source: EAU 2026.

The word is popular but can be misleading. Unlike menopause, men do not undergo a universal, abrupt shutdown of sex-hormone production.

Clinically it is better to talk about specific symptoms and to diagnose late-onset hypogonadism only when symptoms and repeatedly low testosterone are both present.

Source: EAU 2026.

No. Testosterone may change with age, but many older men maintain adequate levels and do not have symptoms of hypogonadism.

Treating age alone would turn normal variation into a disease and expose men to medication they may not need. Symptoms, repeat blood tests and clinical context still matter.

Source: EAU 2026.

There is no over-the-counter supplement that reliably replaces testosterone treatment for confirmed hypogonadism. Products marketed as 'testosterone boosters' often have limited evidence.

Correcting a genuine nutritional deficiency can improve general health, but that does not make booster products treatments for hypogonadism. Some products also contain poorly disclosed mixtures or can interact with medicines.

Source: EAU 2026.

No. Buying testosterone without medical assessment removes the very steps that reduce risk: confirming the diagnosis, investigating the cause, discussing fertility, checking haematocrit and contraindications, and arranging follow-up.

There is also the risk of an uncertain product source. Apparent convenience can mean more risk and a worse diagnosis.

Source: AEMPS CIMA.

No. This is an educational site. It does not sell testosterone, prescribe it or rank commercial TRT providers.

The aim is to explain symptoms, testing, treatment and how the process works in Spain. Links to sources and professional registers are provided for transparency and verification, not as a commercial referral route.

Source: Editorial methodology.